Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 3, 2016, Pages 549-558

  Lu, Yan ^a   Zhu, Mingyue ^a   Li, Wei ^a   Lin, Bo ^a   Dong, Xu ^a   Chen, Yi ^a   Xie, Xieju ^a   Guo, Junli ^a   Li, Mengsen ^a  

^a HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

Alpha fetoprotein; Liver cancer cells metastasis; Therapeutic target

Indexed keywords

ALPHA FETOPROTEIN; CHEMOKINE RECEPTOR CXCR4; CYTOKERATIN 19; EPITHELIAL CELL ADHESION MOLECULE; GELATINASE A; GELATINASE B; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; LIVER CANCER CELL LINE; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RNA INTERFERENCE; TUMOR XENOGRAFT; WESTERN BLOTTING; WOUND HEALING; ADULT; AGED; BLOOD; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SECONDARY; TUMOR CELL LINE; UPREGULATION;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; UP-REGULATION;

EID: 84958665642     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12745     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74-108.
2. Tang ZY. Hepatocellular carcinoma surgery-review of the past and prospects for the 21st century. J Surg Oncol. 2005; 91: 95-6.
3. Llovet JM, Di Bisceglie AM, Bruix J, et al. Panel of experts in HCC-design clinical trials, design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst. 2008; 100: 698-711.
4. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999; 340: 745-50.
5. Li M, Zhu M, Li W, et al. Alpha-fetoprotein receptor as an early indicator of HBx-driven hepatocarcinogenesis and its applications in tracing cancer cell metastasis. Cancer Lett. 2013; 330: 170-80.
6. Ohba T, Yano T, Yoshida T, et al. Results of a surgical resection of pulmonary metastasis from hepatocellular carcinoma: prognostic impact of the preoperative serum alpha-fetoprotein level. Surg Today. 2012; 42: 526-31.
7. Li M, Li H, Li C, et al. Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel7402 cells. Cancer Lett. 2009; 285: 190-9.
8. Li MS, Li PF, He SP, et al. The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line. World J Gastroenterol. 2002; 8: 469-75.
9. Govaere O, Komuta M, Berkers J, et al. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut. 2014; 63: 674-85.
10. Schulze K, Gasch C, Staufer K, et al. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma. Int J Cancer. 2013; 133: 2165-71.
11. Gao J, Ding F, Liu Q, et al. Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9. Mol Cell Biochem. 2013; 376: 21-32.
12. Xiang ZL, Zeng ZC, Tang ZY, et al. Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival. BMC Cancer. 2009; 9: 176.
13. Ni J, Cozzi P, Hao J, et al. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway. Int J Biochem Cell Biol. 2013; 45: 2736-48.
14. Dilly AK, Ekambaram P, Guo Y, et al. Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-κB. Int J Cancer. 2013; 133: 1784-91.
15. Li X, Yang Z, Song W, et al. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)-2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway. Int J Oncol. 2013; 43: 793-802.
16. Mo W, Chen J, Patel A, et al. CXCR4/CXCL12 mediate autocrine cell-cycle progression in NF1-associated malignant peripheral nerve sheath tumors. Cell. 2013; 152: 1077-90.
17. Li M, Li H, Li C, et al. Alpha-fetoprotein: a new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell lines. Int J Cancer. 2011; 128: 524-32.
18. Yokoo H, Kondo T, Fujii K, et al. Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells. Hepatology. 2004; 40: 609-17.
19. Li M, Li H, Li C, et al. Alpha fetoprotein is a novel protein-binding partner for caspase-3 and blocks the apoptotic signaling pathway in human hepatoma cells. Int J Cancer. 2009; 124: 2845-54.
20. Wang Y, Zhang H, Chen Y, et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell. 2009; 138: 660-72.
21. Zheng L, Gong W, Liang P, et al. Effects of AFP-activated PI3K/Akt signaling pathway on cell proliferation of liver cancer. Tumour Biol. 2014; 35: 4095-9.
22. Podsypanina K, Du YC, Jechlinger M, et al. Seeding and propagation of untransformed mouse mammary cells in the lung. Science. 2008; 321: 1841-4.
23. Ho HK, Pok S, Streit S, et al. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. J Hepatol. 2009; 50: 118-27.
24. Nakao K, Ichikawa T. Recent topics on α-fetoprotein. Hepatol Res. 2013; 43: 820-5.
25. Yang X, Zhang Y, Zhang L, et al. Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell. Cancer Lett. 2008; 271: 281-93.
26. Wang XW, Xu B. Stimulation of tumor-cell growth by alpha-fetoprotein. Int J Cancer. 1998; 75: 596-9.
27. Hung TM, Hu RH, Ho CM, et al. Downregulation of alpha-fetoprotein expression by LHX4: a critical role in hepatocarcinogenesis. Carcinogenesis. 2011; 32: 1815-23.
28. Li MS, Li PF, Yang FY, et al. The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells. Cell Res. 2002; 12: 151-6.
29. Wang S, Jiang W, Chen X, et al. Alpha-fetoprotein acts as a novel signal molecule and mediates transcription of Fn14 in human hepatocellular carcinoma. J Hepatol. 2012; 57: 322-9.
30. Yamashita T, Honda M, Nakamoto Y, et al. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Hepatology. 2013; 57: 1484-97.
31. Oishi N, Yamashita T, Kaneko S. Molecular biology of liver cancer stem cells. Liver Cancer. 2014; 3: 71-84.
32. Kim H, Park YN. Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics. Dig Dis. 2014; 32: 778-85.
33. Lin ML, Lu YC, Chen HY, et al. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells. Mol Carcinog. 2014; 53: 360-79.
34. Mukhopadhyay C, Zhao X, Maroni D, et al. Distinct effects of EGFR ligands on human mammary epithelial cell differentiation. PLoS ONE. 2013; 8: e75907.
35. Zhu M, Guo J, Li W, et al. Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells. Oncotarget. 2015; 6: 12196-208.
36. Zhu M, Guo J, Xia H, et al. Alpha-fetoprotein activates AKT/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells. Oncoscience. 2015; 2: 62-73.
37. Gao R, Cai C, Gan J, et al. miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells. Oncotarget. 2015; 6: 6014-28.